M. Nasrallah

Quantitative, longitudinal measurements of response to immunotherapy for glioblastoma using multiparametric MRI in a long-term survivor treated with autologous tumor lysate–loaded dendritic cell vaccine: an illustrative case

Neurosurgeons are in the forefront of developing clinical trials that harness the immune system to combat glioblastoma. Autologous tumor lysate–loaded dendritic cell vaccine (DCVax-L) is a novel immunotherapy for glioblastoma. An unmet need is to develop a sensitive, specific, feasible, clinically relevant, neuroim...

Multimodal Explainable Arti fi cial Intelligence for Prognostic Strati fi cation of Patients With Glioblastoma

Structural Brain Networks and the Seizure-Survival Paradox in Glioblastoma

Structural connectivity partially mediates the seizure-survival association, suggesting preserved network architecture may contribute to why seizure patients survive longer, though the majority of the effect operates through other pathways.